Description
PathoQuest-Biotechnology Research, USA-France The company conducts research on innovative biopharmaceuticals under complex testing conditions on two continents. PathoQuest offers a proven next-generation sequencing (NGS) approach to biosafety testing for the characterization and release of biological products for global biopharmaceutical and emerging biopharmaceutical companies. It is particularly emphasized that the company follows the strictest protocols for ensuring biological safety. At the same time, they were unable to ensure the security of their computer systems. Absolutely all of the company's developments were made publicly available. In addition, the published data contains information on all of the company's clients, as well as actual research, which may differ from the information that customers submit to regulatory authorities. The personal data of all employees, financial documents, and the company's work plans for the coming years have also been published. The leak could seriously damage the company's public image and destroy its reputation.
Leaked Info
Personal data, Internal documents, Health information, Financial data